GeoVax Labs (GOVX) Other Working Capital Changes (2010 - 2025)
GeoVax Labs (GOVX) posted quarterly Other Working Capital Changes of $674826.0 for Q4 2025, up 101730.42% quarter-over-quarter from -$664.0 in Q3 2025.
GeoVax Labs (GOVX) Other Working Capital Changes (2010 - 2025) Analysis & Trends
GeoVax Labs (GOVX) has reported Other Working Capital Changes for 16 consecutive years, with $674826.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Working Capital Changes changed N/A year-over-year to $674826.0; the TTM figure through Dec 2025 stood at $414544.0 (up 137.12% YoY), while the FY2025 annual figure was $414544.0, up 137.12% from the prior year.
- Other Working Capital Changes climbed to $674826.0 in Q4 2025 per GOVX's latest filing, from -$664.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.2 million in Q3 2022 and bottomed at -$2.0 million in Q2 2024.
- Historically, Other Working Capital Changes has averaged $28871.4 across 5 years, with a median of -$10000.0 in 2022.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes surged 3456.08% — and 2023, when it slumped 805.73%.
- GeoVax Labs' Other Working Capital Changes stood at $123249.0 in 2021, then sank by 108.11% to -$10000.0 in 2022, then changed by 0.0% to -$10000.0 in 2023, then changed by 0.0% to -$10000.0 in 2024, then surged by 6848.26% to $674826.0 in 2025.
- Business Quant data shows GOVX's Other Working Capital Changes at $674826.0 in Q4 2025, -$664.0 in Q3 2025, and -$167178.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GeoVax Labs | 2.88 Mn | -260,493.75 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 674,826.00 |
| Dec 31, 2025 | 674,826.00 |
| Dec 31, 2025 | 674,826.00 |
| Sep 30, 2025 | -664.00 |
| Sep 30, 2025 | -664.00 |
| Sep 30, 2025 | -664.00 |
| Jun 30, 2025 | -167,178.00 |
| Jun 30, 2025 | -167,178.00 |
| Jun 30, 2025 | -167,178.00 |
| Mar 31, 2025 | -92,440.00 |
| Mar 31, 2025 | -92,440.00 |
| Mar 31, 2025 | -92,440.00 |
| Sep 30, 2024 | -10,000.00 |
| Sep 30, 2024 | -10,000.00 |
| Sep 30, 2024 | -10,000.00 |
| Jun 30, 2024 | -1.99 Mn |
| Jun 30, 2024 | -1.99 Mn |
| Jun 30, 2024 | -1.99 Mn |
| Mar 31, 2024 | 882,097.00 |
| Mar 31, 2024 | 882,097.00 |